Minimally Invasive Approaches in the Treatment of BPH: Ready to Replace TURP? - Claus Roehrborn
November 15, 2018
Claus Roehrborn provides a state of the art review on contemporary management of male lower urinary tract symptoms and BPH.
Claus Roehrborn, MD is at the Harold C. Simmons Comprehensive Cancer Center. Dr. Roehrborn is the S.T. Harris Family Chair in Medical Science, in Honor of John D. McConnell, M.D. and the E.E. Fogelson and Greer Garson Fogelson Distinguished Chair in Urology. A world-renowned urologist and expert on cancerous prostate diseases, Claus Roehrborn, M.D., has been practicing at UT Southwestern for more than 20 years and has been Chair of the Department of Urology since 2002. Under his leadership, the Department has consistently been named among the nation’s best by U.S. News & World Report.
Dr. Roehrborn’s practice focuses on the treatment of prostate cancer and benign prostatic hyperplasia (BPH). Over the past several years, he has performed more than 1,200 robotic prostatectomies for prostate cancer and more than 800 laser prostatectomies for BPH, making him one of the country’s most experienced surgeons in the use of robotic procedures for urologic conditions. In addition, he is involved in virtually all aspects of BPH research as well as translational and clinical research in prostatitis and prostate cancer.